Royalty Pharma
RPRX
#620
Rank
โ‚ฌ35.85 B
Marketcap
62,37ย โ‚ฌ
Share price
-0.01%
Change (1 day)
83.04%
Change (1 year)

Operating Margin for Royalty Pharma (RPRX)

Operating Margin as of November 2026 (TTM): 59.01%

According to Royalty Pharma's latest financial reports and stock price the company's current Operating Margin is 59.01%. At the end of 2025 the company had an Operating Margin of 55.68%.

Operating Margin history for Royalty Pharma from 2019 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
202555.68%-5.29%
202458.79%-18.57%
202372.20%602.14%
202210.28%-81.03%
202154.21%-32.4%
202080.19%-40.89%
2019135.67%60.43%
201884.57%0.6%
201784.06%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Abbott Laboratories
ABT
15.35%-73.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
40.21%-31.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
15.15%-74.33%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.